Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Takeda Pharmaceutical Company Limited

Market Cap 7,801B 48.57B 42.22B 38.8B 36.53B 68.46B 4,597B 69.24B 458B 179B 2,255B 182B 178B P/E 2026
46.4x
P/E 2027 * 40.2x
Enterprise Value 11,741B 73.1B 63.54B 58.39B 54.98B 103B 6,918B 104B 690B 269B 3,394B 274B 268B EV / Sales 2026
1.14x
EV / Sales 2027 * 2.53x
Free-Float
99.25%
Yield 2026
3.53%
Yield 2027 * 4.14%
1 day-1.63%
1 week-0.74%
Current month-3.52%
1 month-6.42%
3 months-13.93%
6 months+9.30%
Current year+2.13%
1 week 4,938
Extreme 4938
5,158
1 month 4,710
Extreme 4710
5,362
Current year 4,710
Extreme 4710
6,033
1 year 4,102
Extreme 4102
6,033
3 years 3,852
Extreme 3852
6,033
5 years 2,993
Extreme 2993
6,033
10 years 2,894.5
Extreme 2894.5
6,693
Manager TitleAgeSince
Chief Executive Officer 59 2015-03-31
Director of Finance/CFO 48 2024-03-31
Chief Tech/Sci/R&D Officer 47 2022-01-31
Director TitleAgeSince
Director/Board Member 74 2016-05-31
Director/Board Member 69 2016-05-31
Director/Board Member 65 2018-12-31
Date Insider Type Main position Quantity % Market Cap.
04-26Free

Chief Technology Officer

212,470 0.0134%
04-26Free

Chief Financial Officer

15,614 0.0010%
04-26Free

Executive/Senior Manager

27,740 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
-1.63%-0.74%+13.88%+8.01% 49.43B
-0.94%-2.85%+37.70%+148.38% 1,001B
-0.42%-1.18%+50.88%+42.60% 566B
-0.56%-1.86%+15.91%+59.57% 393B
-1.18%+2.29%+24.04%+16.53% 326B
+1.09%+2.21%+25.56%+33.32% 276B
+1.42%-1.17%+24.53%+14.29% 277B
+1.87%+5.96%-42.67%-48.26% 193B
-1.78%-0.84%+15.60%+48.77% 188B
-1.40%-0.04%+13.19%+59.08% 158B
Average -0.13%+0.41%+17.86%+38.23% 342.62B
Weighted average by Cap. +0.08%-0.39%+26.83%+65.43%

Financials

2026 2027 *
Net sales 4,531B 28.21B 24.52B 22.53B 21.22B 39.77B 2,670B 40.22B 266B 104B 1,310B 106B 104B 4,630B 28.83B 25.06B 23.03B 21.68B 40.64B 2,728B 41.09B 272B 106B 1,338B 108B 106B
Net income 174B 1.09B 944M 868M 817M 1.53B 103B 1.55B 10.25B 4B 50.43B 4.08B 3.99B 184B 1.14B 995M 915M 861M 1.61B 108B 1.63B 10.8B 4.21B 53.16B 4.3B 4.21B
Net Debt 3,940B 24.53B 21.32B 19.59B 18.45B 34.57B 2,321B 34.96B 231B 90.3B 1,139B 92.06B 90.09B 3,914B 24.37B 21.19B 19.47B 18.33B 34.35B 2,307B 34.74B 230B 89.72B 1,132B 91.47B 89.52B
Logo Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Employees
47,455
Date Price Change Volume
26-06-17 4,938.00 ¥ -1.63% 3,890,400
26-06-16 5,020.00 ¥ -1.34% 3,072,600
26-06-15 5,088.00 ¥ +0.12% 3,450,400
26-06-12 5,082.00 ¥ +0.97% 4,711,800
26-06-11 5,033.00 ¥ -0.73% 2,623,200
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
4,938.00JPY
Average target price
6,086.87JPY
Spread / Average Target
+23.27%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4502 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!